Large populational study finds prior SARS-CoV-2 infection reduces the risk of breakthrough infection following mRNA vaccination.
Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar – JAMA Commentaries: Vaccine plus previous infection may offer enhanced COVID-19 protection – CIDRAP Prior SARS-CoV-2 infection and risk of breakthrough infection following mRNA vaccination – News Medical Commentary on Twitter Study found prior #SARSCoV2 infection was associated with […]
The post Large populational study finds prior SARS-CoV-2 infection reduces the risk of breakthrough infection following mRNA vaccination. appeared first on Links Medicus.
Phase 4 RCT: Concomitant administration of COVID-19 vaccines (AstraZeneca or Pfizer) with seasonal influenza vaccines in adults is safe and preserves antibody responses to both vaccines.
Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial – The Lancet
The post Phase 4 RCT: Concomitant administration of COVID-19 vaccines (AstraZeneca or Pfizer) with seasonal influenza vaccines in adults is safe and preserves antibody responses to both vaccines. appeared first on Links Medicus.
ERS Guidelines: High-flow nasal cannula in acute respiratory failure.
ERS Clinical Practice Guidelines: High-flow nasal cannula in acute respiratory failure – European Respiratory Journal
The post ERS Guidelines: High-flow nasal cannula in acute respiratory failure. appeared first on Links Medicus.
2022 ASA Guidelines for Management of the Difficult Airway.
2022 American Society of Anesthesiologists Practice Guidelines for Management of the Difficult Airway – Anesthesiology Related: Consensus-based recommendations for management of the difficult airway: part 1. Difficult airway management encountered in an unconscious patient. Difficult airway management in neonates and infants: knowledge of devices and a device-oriented strategy. Consensus Guideline: Pediatric Airway Management in COVID-19 […]
The post 2022 ASA Guidelines for Management of the Difficult Airway. appeared first on Links Medicus.
Global surveillance, research, and collaboration needed to improve understanding and management of long COVID.
Global surveillance, research, and collaboration needed to improve understanding and management of long COVID – The Lancet Related: Provocative study suggests that persistent physical symptoms after COVID-19 infection may be associated more with the belief in having been infected with SARS-CoV-2 than with having laboratory-confirmed COVID-19 infection. Update to post-acute sequelae of SARS-CoV-2 infection: Caring […]
The post Global surveillance, research, and collaboration needed to improve understanding and management of long COVID. appeared first on Links Medicus.
Boosting immunity to COVID-19 vaccines – “New studies highlight the immunological benefits of COVID-19 vaccine boosters, but questions remain over how to best make use of a limited global supply”.
Boosting immunity to COVID-19 vaccines – Nature Medicine
The post Boosting immunity to COVID-19 vaccines – “New studies highlight the immunological benefits of COVID-19 vaccine boosters, but questions remain over how to best make use of a limited global supply”. appeared first on Links Medicus.
Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method.
Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method – The Lancet Infectious Diseases Commentary from the author on Twitter (thread – click for more) Honoured to lead this Delphi on Infection Control in ICU for SARS-CoV-2 with global experts https://t.co/39NTHgfyZR @Drnasap @ElieAzoulay5 @jigidivatia @AlhazzaniW @NaomiHammond @criticcaredoc […]
The post Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method. appeared first on Links Medicus.
RCT: BBV152 (India’s COVAXIN) has an overall vaccine efficacy of 77.8% against symptomatic Covid-19 in adults.
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial – The Lancet Invited Commentary: Inactivated SARS-CoV-2 vaccine (BBV152)-induced protection against symptomatic COVID-19 – The Lancet Related: WHO issues emergency use approval for India’s Covaxin. Commentary on Twitter NEW—Interim data from a phase […]
The post RCT: BBV152 (India’s COVAXIN) has an overall vaccine efficacy of 77.8% against symptomatic Covid-19 in adults. appeared first on Links Medicus.
M-A: Low vitamin D levels do not aggravate COVID-19 risk or death, and vitamin D supplementation does not improve outcomes in hospitalized patients with COVID-19.
Low vitamin D levels do not aggravate COVID-19 risk or death, and vitamin D supplementation does not improve outcomes in hospitalized patients with COVID-19: a meta-analysis and GRADE assessment of cohort studies and RCTs – Nutritional Journal
The post M-A: Low vitamin D levels do not aggravate COVID-19 risk or death, and vitamin D supplementation does not improve outcomes in hospitalized patients with COVID-19. appeared first on Links Medicus.
Perspective | COVID’s endgame: Scientists have a clue about where SARS-CoV-2 is headed.
COVID’s endgame: Scientists have a clue about where SARS-CoV-2 is headed – NPR
The post Perspective | COVID’s endgame: Scientists have a clue about where SARS-CoV-2 is headed. appeared first on Links Medicus.